Acid Maltase Deficiency
5 clinical trials · Condition
◉ Watch Acid Maltase Deficiency
| Record | Firm | Date |
|---|---|---|
| A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) (NCT04093349) | Spark Therapeutics, Inc. | 2020-10-01 |
| Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease (NCT03893240) | Spark Therapeutics, Inc. | 2019-06-12 |
| Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. (NCT01898364) | Genzyme, a Sanofi Company | 2013-08-19 |
| A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease (NCT01597596) | Genzyme, a Sanofi Company | 2012-08-01 |
Track Acid Maltase Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.